What is it?
Oral solution for the combination therapy to antihypertensive treatment in glaucoma patients based on Cognizin® citicoline (50 mg / ml).
Food for special medical purposes, based on citicoline 50 mg/ml, indicated for dietary treatment of glaucoma patients, pharmacologically stabilised and with progressive loss of the visual field.
Citicoline promotes the biosynthesis of phospholipids of the optic nerve membrane. This structural action improves the function of mechanisms essential for correct neurotransmission. Citicoline maintains neuronal function, inhibits apoptosis and stimulates acetylcholine and dopamine synthesis. These neurotransmitters are involved in the conduction of the visual stimulus, both at the retinal and post-retinal level (central nervous system).
